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Abstract: The crystal structures of the title adamantane-oxadiazole hybrid compounds, C18H19FN2O
(I) and C18H19ClN2O (II), are built up from an adamantane unit and a halogenophenyl ring, [X = F
(I), Cl (Mb in position 5 on the central 1,3,4-oxadiazole unit. The molecular structures are very similar,
only the relative orientation of the halogenophenyl ring in comparison with the central five membered
ring differs slightly. In the crystals of both compounds, molecules are linked by pairs of C-H center dot
center dot center dot N hydrogen bonds, forming inversion dimers with R-2(2)(12) ring motifs. In (I) the
dimers are connected by C-H center dot center dot center dot F interactions, forming slabs lying parallel
to the be plane. In (II), the dimers are linked by C-H center dot center dot center dot pi and offset pi-pi
interactions [interplanar distance = 3.4039 (9) angstrom], forming layers parallel to (10 (1) over bar).
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The crystal structures of the title adamantane-oxadiazole hybrid compounds,
C18H19FN2O (I) and C18H19ClN2O (II), are built up from an adamantane unit
and a halogenophenyl ring, [X = F (I), Cl (II)], in position 5 on the central 1,3,4-
oxadiazole unit. The molecular structures are very similar, only the relative
orientation of the halogenophenyl ring in comparison with the central five-
membered ring differs slightly. In the crystals of both compounds, molecules are
linked by pairs of C—H  N hydrogen bonds, forming inversion dimers with
R22(12) ring motifs. In (I) the dimers are connected by C—H  F interactions,
forming slabs lying parallel to the bc plane. In (II), the dimers are linked by C—
H   and offset – interactions [interplanar distance = 3.4039 (9) A˚], forming
layers parallel to (101).
1. Chemical context
Considerable attention has been devoted to adamantane
derivatives, which have long been known for their diverse
biological properties (Liu et al., 2011; Lamoureux & Artavia,
2010). In view of the pronounced lipophilicity of the
adamantane cage, it has been observed that adamantyl-
bearing compounds are characterized by high therapeutic
indices (Wanka et al., 2013). Sixty years ago, the first
adamantane-based drug, amantadine, was discovered to be an
efficient therapy for the treatment of Influenza A infection
(Davies et al., 1964; Togo et al., 1968). As a result of intensive
research based on adamantane derivatives, the adamantane
nucleus was further recognized as the key pharmacophore in
several biologically active compounds. Among the major
biological activities displayed by adamantane derivatives, the
anti-HIV (El-Emam et al., 2004; Burstein et al., 1999; Balzarini
et al., 2009), antibacterial (Protopopova et al., 2005; El-Emam
et al., 2013; Kadi et al., 2010; Al-Abdullah et al., 2014; Al-
Wahaibi et al., 2017), antifungal (Omar et al., 2010), anticancer
(Sun et al., 2002), anti-diabetic (Villhauer et al., 2003; Augeri et
al., 2005) and antimalarial (Dong et al., 2010) activities are the
most interesting. In addition, 1,3,4-oxadiazole derivatives
occupy a unique place in the field of medicinal chemistry as
pharmacophores or auxophores possessing diverse pharma-
cological activities including antibacterial (Prakash et al., 2010;
Ogata et al., 1971; Kadi et al., 2007), anticancer (Zhang et al.,
ISSN 2056-9890
2014), antiviral (Wu et al., 2015) and anti-inflammatory
(Bansal et al., 2014) activities. We report herein on the crystal
structure determinations of the title adamantane-oxadiazole
hybrid molecules 2-(adamantan-1-yl)-5-(4-fluorophenyl)-
1,3,4-oxadiazole (I) and 2-(adamantan-1-yl)-5-(4-chlorophen-
yl)-1,3,4-oxadiazole (II). The crystal structure of the 4-
bromophenyl derivative has been reported previously
(Alzoman et al., 2014), and after examination of the deposited
CIF and transformation of the space group, from P21/c to P21/
n, it is found to be isotypic with compound (II).
2. Structural commentary
Compounds (I) and (II), are built up from a central 1,3,4-
oxadiazole unit, an adamantane unit and a halogenophenyl
group (Figs. 1 and 2, respectively). The C—N bonds in the
oxadiazole rings have double-bond character [C7 N1 =
1.279 (5) and 1.292 (3) A˚, and C8 N2 = 1.288 (5) and
1.288 (3) A˚ in (I) and (II), respectively], while the N—N and
C—O bonds exhibit single-bond character [N1—N2 =
1.408 (4) and 1.417 (3) A˚, C7—O1 = 1.366 (4) and 1.360 (2) A˚,
and C8—O1 = 1.369 (4) and 1.359 (2) A˚ in (I) and (II),
respectively]. These geometrical parameters are very similar
to those observed for similar compounds; see x5. Database
survey.
As seen in Fig. 3, the molecular structures of compounds (I)
and (II) are very similar. The largest difference is highlighted
by the structural overlay plot, and comes from the relative
orientation of the halogenophenyl group with respect to the
oxadiazole ring. In compound (II), the rings are almost
coplanar with their mean planes being inclined to each other
by 9.5 (1), while in compound (I) the equivalent dihedral
angle is 20.8 (2).
3. Supramolecular features
In the crystals of both compounds, molecules are linked by
pairs of C—H  N hydrogen bonds, forming inversion dimers
with R22(12) ring motifs (Tables 1 and 2, respectively). In the
crystal of (I), the dimers are connected by C—H  F inter-
actions, forming slabs lying parallel to the bc plane (Fig. 4 and
Table 1). In the crystal of (II), the dimers are linked by C—
H   and offset – interactions, forming layers lying
parallel to the (101) plane; see Fig. 5 and Table 2. The offset –
 interactions involve inversion-related 4-chlorophenyl rings
(C1–C6) with an intercentroid distance of 3.687 (1) A˚, an
interplanar distance of 3.404 (1) A˚, and an offset of 1.418 A˚.
In Fig. 5 these interactions are represented by double-headed
red arrows.
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Figure 2
Molecular structure of compound (II), with the atom labelling and
displacement ellipsoids drawn at the 50% probability level.
Figure 3
View of the structural overlay of compounds (I) and (II). Compound (I) is
drawn according to element type, while compound (II) is drawn in pale
green.
Figure 1
Molecular structure of compound (I), with the atom labelling and
displacement ellipsoids drawn at the 50% probability level.
Table 1
Hydrogen-bond geometry (A˚, ) for (I).
Cg1 is the centroid of the C1–C6 ring.
D—H  A D—H H  A D  A D—H  A
C3—H3  N1i 0.95 2.56 3.383 (5) 146
C18—H18A  F1ii 0.99 2.47 3.415 (5) 159
Symmetry codes: (i) xþ 1;yþ 1;zþ 1; (ii) xþ 1; y 12;z þ 32.
Table 2
Hydrogen-bond geometry (A˚, ) for (II).
Cg1 is the centroid of the C1–C6 ring.
D—H  A D—H H  A D  A D—H  A
C3—H3  N1i 0.95 2.61 3.386 (3) 139
C12—H12A  Cg1ii 0.99 2.73 3.680 (3) 160
Symmetry codes: (i) xþ 1;y;zþ 1; (ii) xþ 12;yþ 12; z þ 12.
4. Hirshfeld surface analysis
The Hirshfeld surfaces for (I) and (II) mapped over dnorm were
calculated using CrystalExplorer 17 (Turner et al., 2017) with
the default setting of arbitrary units range. The characteristic
bright-red spots near atoms H3, H18A, N1 and F1 (Fig. 6)
confirm the previously mentioned C3—H3  N1i and C18—
H18A  F1ii [symmetry codes: (i) x + 1, y + 1, z + 1; (ii)
x + 1, y  12, z + 32] interatomic contacts in the crystal
packing of (I). As expected, the same bright-red spots are
observed near atoms H3 and N1 on the Hirshfeld surface of
(II); see Fig. 7. The Hirshfeld surface mapped over the shape-
index property elegantly illustrates the – stacking and the
C—H   interactions observed in the crystal packing of (II).
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Figure 6
Aview of the Hirshfeld surface mapped over dnorm for compound (I) over
the range 0.138 to 1.364 arbitrary units.
Figure 7
A view of the Hirshfeld surface mapped over dnorm for compound (II)
over the range 0.203 to 1.273 arbitrary units.
Figure 4
A view along the b axis of the crystal packing of compound (I). The
hydrogen-bonding interactions (see Table 1) are shown as dashed lines.
For clarity, only hydrogen atoms H3 and H18A have been included.
Figure 5
Aview along the b axis of the crystal packing of compound (II), showing
the C—H  N hydrogen bonds and the C—H   interactions (see
Table 2) as dashed lines. The offset – interactions are indicated by
double-headed red arrows. For clarity, only hydrogen atoms H3 and
H12A have been included.
Figure 8
Two views, (a) and (b), of the Hirshfeld surface mapped over the shape-
index property for compound (II).
Two views are presented in Fig. 8. The – stacking between
inversion-related 4-chlorophenyl rings (C1–C6) is indicated by
the appearance of small blue regions surrounding a bright-red
triangle within the six-membered ring (Fig. 8a), while the
C12—H12A  (C1–C6)iii interaction [symmetry code: (iii)
x + 12,y + 12, z + 12] appears as a large red region within the ring
(Fig. 8b).
5. Database survey
A search of the Cambridge Structural Database (CSD, version
5.40, February 2019; Groom et al., 2016) for the substructure
2-(adamantan-1-yl)-1,3,4-oxadiazole gave five hits. The crystal
structures of three very similar compounds were reported in
the last decade, namely 2-(adamantan-1-yl)-5-(4-nitrophenyl)-
1,3,4-oxadiazole (CSD refcode LAPVOP; El-Emam et al.,
2012), which has an NO2 group on the phenyl ring (in the para
position to the oxadiazole ring), 2-(adamantan-1-yl)-5-(4-
bromophenyl)-1,3,4-oxadiazole (SOSXIJ; Alzoman et al.
2014), which has a Br atom on the phenyl ring (same para
position) and 2-(adamantan-1-yl)-5-(3-fluorophenyl)-1,3,4-
oxadiazole (SIKKAA; Khan et al., 2012), with a 3-fluoro-
phenyl substituent at position 5 on the oxadiazole ring. Two
more recently reported structures are (5-(adamantan-1-
yl)-1,3,4-oxadiazole-2-thiolato)triphenylphosphinegold(I)
(AZECAL; Garcia et al., 2016) and 2-(adamantan-1-yl)-
5-[2-(2-methylphenyl)-1,3-thiazol-4-yl]-1,3,4-oxadiazole
(XARGEE01; Khan et al., 2016).
The reduced cell of SOSXIJ indicates that it is isotypic with
compound (II). Compound LAPVOP resides on a mirror
plane, while compound SIKKAA crystallizes with two inde-
pendent molecules in the asymmetric unit. The geometrical
parameters of the oxadiazole rings are similar to those
reported above for the title compounds. The 4-substituted
phenyl rings are inclined to the oxadiazole ring by 0.0 in
LAPVOP (as it lies in a mirror plane), 3.01 and 3.31 in the
two independent molecules of SIKKAA and 10.44 in
SOSXIJ. In the title compounds the corresponding dihedral
angle is 20.8 (2) for compound (I) and 9.5 (1) for compound
(II).
6. Synthesis and crystallization
Compounds (I) and (II) were synthesized via condensation of
adamantane-1-carboxylic acid with 4-fluorobenzohydrazide,
or 4-chlorobenzohydrazide in the presence of phosphorus
oxychloride, as described previously (Kadi et al., 2007).
Colourless plate-like crystals of compound (I) and colourless
needle-like crystals of compound (II) were obtained by slow
evaporation of CHCl3:EtOH (1:1 v:v) solutions at room
temperature.
7. Refinement
Crystal data, data collection and structure refinement details
are summarized in Table 3. All H atoms were placed in






Chemical formula C18H19FN2O C18H19ClN2O
Mr 298.35 314.80
Crystal system, space group Monoclinic, P21/c Monoclinic, P21/n
Temperature (K) 160 160
a, b, c (A˚) 18.2525 (4), 7.07855 (16), 11.2207 (2) 13.08241 (19), 6.49259 (9), 18.5129 (3)
 () 98.556 (2) 105.5609 (16)
V (A˚3) 1433.59 (6) 1514.83 (4)
Z 4 4
Radiation type Cu K Cu K
 (mm1) 0.78 2.25
Crystal size (mm) 0.18  0.15  0.02 0.33  0.12  0.08
Data collection
Diffractometer XtaLAB Synergy, Dualflex, Pilatus 200K XtaLAB Synergy, Dualflex, Pilatus 200K
Absorption correction Analytical (CrysAlis PRO; Rigaku OD, 2019) Analytical (CrysAlis PRO; Rigaku OD, 2019)
Tmin, Tmax 0.921, 0.990 0.642, 0.870
No. of measured, independent and
observed [I > 2(I)] reflections





R[F 2 > 2(F 2)], wR(F 2), S 0.080, 0.233, 1.23 0.061, 0.167, 1.08
No. of reflections 2903 3217
No. of parameters 199 199
H-atom treatment H-atom parameters constrained H-atom parameters constrained
	max, 	min (e A˚
3) 0.47, 0.38 0.81, 0.26
Computer programs: CrysAlis PRO (Rigaku OD, 2019), SHELXT (Sheldrick, 2015a), SHELXL (Sheldrick, 2015b), Mercury (Macrae et al., 2008) and OLEX2 (Dolomanov et al.,
2009).
calculated positions and treated as riding atoms: C—H = 0.95–
1.00 A˚ with Uiso = 1.2Ueq(C).
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Computing details 
For both structures, data collection: CrysAlis PRO (Rigaku OD, 2019); cell refinement: CrysAlis PRO (Rigaku OD, 
2019); data reduction: CrysAlis PRO (Rigaku OD, 2019); program(s) used to solve structure: ShelXT (Sheldrick, 2015a); 
program(s) used to refine structure: SHELXL (Sheldrick, 2015b); molecular graphics: Mercury (Macrae et al., 2008); 






a = 18.2525 (4) Å
b = 7.07855 (16) Å
c = 11.2207 (2) Å
β = 98.556 (2)°
V = 1433.59 (6) Å3
Z = 4
F(000) = 632
Dx = 1.382 Mg m−3
Cu Kα radiation, λ = 1.54184 Å
Cell parameters from 7588 reflections
θ = 4.9–78.5°
µ = 0.78 mm−1
T = 160 K
Plate, colourless
0.18 × 0.15 × 0.02 mm
Data collection 
XtaLAB Synergy, Dualflex, Pilatus 200K 
diffractometer
Radiation source: micro-focus sealed X-ray 
tube, PhotonJet (Cu) X-ray Source
Mirror monochromator
Detector resolution: 5.8140 pixels mm-1
ω scans
Absorption correction: analytical 
(CrysAlisPro; Rigaku OD, 2019)
Tmin = 0.921, Tmax = 0.990
13058 measured reflections
2903 independent reflections
2578 reflections with I > 2σ(I)
Rint = 0.030













Primary atom site location: dual
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0572P)2 + 6.0123P] 
where P = (Fo2 + 2Fc2)/3
supporting information
sup-2Acta Cryst. (2019). E75, 611-615    
(Δ/σ)max < 0.001
Δρmax = 0.47 e Å−3
Δρmin = −0.38 e Å−3
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
C1 0.6397 (2) 0.5834 (6) 0.8751 (3) 0.0220 (8)
C2 0.6287 (2) 0.5485 (6) 0.7528 (3) 0.0218 (8)
H2 0.669009 0.519350 0.711237 0.026*
C3 0.5568 (2) 0.5574 (5) 0.6928 (3) 0.0189 (7)
H3 0.547397 0.536452 0.608242 0.023*
C4 0.4979 (2) 0.5973 (5) 0.7558 (3) 0.0178 (7)
C5 0.5114 (2) 0.6345 (5) 0.8784 (3) 0.0201 (8)
H5 0.471482 0.664740 0.920495 0.024*
C6 0.5836 (2) 0.6276 (6) 0.9397 (3) 0.0234 (8)
H6 0.593767 0.652639 1.023700 0.028*
C7 0.42268 (19) 0.5993 (5) 0.6869 (3) 0.0188 (7)
C8 0.3054 (2) 0.5755 (5) 0.6523 (3) 0.0194 (8)
C9 0.22741 (19) 0.5532 (5) 0.6776 (3) 0.0188 (8)
C10 0.2034 (2) 0.7286 (6) 0.7450 (4) 0.0229 (8)
H10A 0.235907 0.742685 0.823383 0.027*
H10B 0.208148 0.843843 0.696746 0.027*
C11 0.1226 (2) 0.7041 (6) 0.7656 (4) 0.0249 (9)
H11 0.107002 0.816945 0.809285 0.030*
C12 0.0729 (2) 0.6855 (7) 0.6436 (4) 0.0280 (9)
H12A 0.020522 0.672769 0.656054 0.034*
H12B 0.077248 0.800506 0.594894 0.034*
C13 0.0958 (2) 0.5124 (6) 0.5766 (3) 0.0261 (9)
H13 0.063156 0.501154 0.496999 0.031*
C14 0.1769 (2) 0.5336 (6) 0.5561 (3) 0.0241 (8)
H14A 0.191844 0.421626 0.512660 0.029*
H14B 0.181982 0.646678 0.506007 0.029*
C15 0.1155 (2) 0.5267 (7) 0.8408 (4) 0.0282 (9)
H15A 0.147857 0.538200 0.919522 0.034*
H15B 0.063748 0.512872 0.855987 0.034*
C16 0.1378 (2) 0.3532 (6) 0.7743 (4) 0.0264 (9)
H16 0.132697 0.237763 0.823688 0.032*
C17 0.0881 (2) 0.3342 (6) 0.6516 (4) 0.0282 (9)
H17A 0.102861 0.221647 0.608557 0.034*
H17B 0.035805 0.318109 0.663834 0.034*
C18 0.2193 (2) 0.3748 (6) 0.7544 (4) 0.0242 (8)
H18A 0.234847 0.261751 0.712615 0.029*
H18B 0.251650 0.386012 0.833140 0.029*
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F1 0.71024 (12) 0.5714 (4) 0.9363 (2) 0.0321 (6)
N1 0.40489 (17) 0.6139 (5) 0.5727 (3) 0.0237 (7)
N2 0.32721 (18) 0.5975 (5) 0.5493 (3) 0.0245 (7)
O1 0.36296 (13) 0.5751 (4) 0.7457 (2) 0.0192 (6)
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
C1 0.0185 (18) 0.0220 (19) 0.0239 (19) −0.0016 (15) −0.0015 (14) 0.0036 (15)
C2 0.0179 (17) 0.0239 (19) 0.0245 (19) −0.0014 (15) 0.0059 (14) 0.0014 (15)
C3 0.0218 (18) 0.0180 (17) 0.0177 (17) 0.0000 (14) 0.0055 (14) −0.0012 (13)
C4 0.0152 (16) 0.0155 (16) 0.0232 (17) −0.0024 (13) 0.0048 (13) 0.0008 (14)
C5 0.0199 (17) 0.0201 (18) 0.0217 (18) 0.0007 (14) 0.0083 (14) 0.0003 (14)
C6 0.028 (2) 0.0220 (19) 0.0204 (18) −0.0023 (16) 0.0029 (15) −0.0004 (15)
C7 0.0170 (17) 0.0187 (17) 0.0220 (18) −0.0004 (14) 0.0074 (14) 0.0000 (14)
C8 0.0182 (17) 0.0217 (19) 0.0178 (17) 0.0005 (14) 0.0014 (13) −0.0002 (14)
C9 0.0163 (17) 0.0260 (19) 0.0141 (16) 0.0021 (14) 0.0015 (13) 0.0001 (14)
C10 0.0163 (18) 0.027 (2) 0.0257 (19) −0.0027 (15) 0.0034 (14) −0.0046 (16)
C11 0.0153 (17) 0.034 (2) 0.027 (2) 0.0003 (16) 0.0061 (14) −0.0057 (17)
C12 0.0159 (18) 0.039 (2) 0.029 (2) 0.0032 (17) 0.0029 (15) 0.0023 (18)
C13 0.0170 (18) 0.041 (2) 0.0191 (18) −0.0018 (16) −0.0021 (14) −0.0039 (17)
C14 0.0179 (18) 0.038 (2) 0.0161 (17) −0.0002 (16) 0.0018 (14) −0.0001 (16)
C15 0.0197 (18) 0.045 (3) 0.0201 (19) −0.0023 (17) 0.0047 (14) −0.0018 (18)
C16 0.0197 (18) 0.031 (2) 0.030 (2) −0.0026 (16) 0.0057 (15) 0.0047 (17)
C17 0.0205 (19) 0.034 (2) 0.030 (2) −0.0060 (17) 0.0046 (16) −0.0061 (18)
C18 0.0211 (18) 0.029 (2) 0.0233 (19) 0.0043 (16) 0.0051 (15) 0.0048 (16)
F1 0.0198 (11) 0.0465 (16) 0.0278 (12) −0.0006 (10) −0.0032 (9) 0.0031 (11)
N1 0.0194 (15) 0.0318 (18) 0.0207 (16) 0.0022 (13) 0.0061 (12) 0.0008 (14)
N2 0.0202 (16) 0.0366 (19) 0.0171 (15) 0.0020 (14) 0.0044 (12) 0.0013 (14)
O1 0.0148 (12) 0.0288 (14) 0.0146 (12) −0.0007 (10) 0.0036 (9) −0.0009 (10)
Geometric parameters (Å, º) 
C1—C2 1.380 (5) C11—H11 1.0000
C1—C6 1.376 (5) C11—C12 1.532 (6)
C1—F1 1.369 (4) C11—C15 1.529 (6)
C2—H2 0.9500 C12—H12A 0.9900
C2—C3 1.384 (5) C12—H12B 0.9900
C3—H3 0.9500 C12—C13 1.528 (6)
C3—C4 1.400 (5) C13—H13 1.0000
C4—C5 1.386 (5) C13—C14 1.539 (5)
C4—C7 1.472 (5) C13—C17 1.535 (6)
C5—H5 0.9500 C14—H14A 0.9900
C5—C6 1.394 (5) C14—H14B 0.9900
C6—H6 0.9500 C15—H15A 0.9900
C7—N1 1.279 (5) C15—H15B 0.9900
C7—O1 1.366 (4) C15—C16 1.523 (6)
C8—C9 1.500 (5) C16—H16 1.0000
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C8—N2 1.288 (5) C16—C17 1.538 (6)
C8—O1 1.369 (4) C16—C18 1.544 (5)
C9—C10 1.550 (5) C17—H17A 0.9900
C9—C14 1.534 (5) C17—H17B 0.9900
C9—C18 1.548 (5) C18—H18A 0.9900
C10—H10A 0.9900 C18—H18B 0.9900
C10—H10B 0.9900 N1—N2 1.408 (4)
C10—C11 1.537 (5)
C6—C1—C2 123.8 (4) H12A—C12—H12B 108.2
F1—C1—C2 118.3 (3) C13—C12—C11 109.8 (3)
F1—C1—C6 117.9 (3) C13—C12—H12A 109.7
C1—C2—H2 121.2 C13—C12—H12B 109.7
C1—C2—C3 117.5 (3) C12—C13—H13 109.5
C3—C2—H2 121.2 C12—C13—C14 109.6 (3)
C2—C3—H3 119.8 C12—C13—C17 109.6 (3)
C2—C3—C4 120.5 (3) C14—C13—H13 109.5
C4—C3—H3 119.8 C17—C13—H13 109.5
C3—C4—C7 117.6 (3) C17—C13—C14 109.3 (3)
C5—C4—C3 120.2 (3) C9—C14—C13 109.9 (3)
C5—C4—C7 122.2 (3) C9—C14—H14A 109.7
C4—C5—H5 120.1 C9—C14—H14B 109.7
C4—C5—C6 119.9 (3) C13—C14—H14A 109.7
C6—C5—H5 120.1 C13—C14—H14B 109.7
C1—C6—C5 118.1 (3) H14A—C14—H14B 108.2
C1—C6—H6 121.0 C11—C15—H15A 109.7
C5—C6—H6 121.0 C11—C15—H15B 109.7
N1—C7—C4 127.2 (3) H15A—C15—H15B 108.2
N1—C7—O1 113.1 (3) C16—C15—C11 110.0 (3)
O1—C7—C4 119.7 (3) C16—C15—H15A 109.7
N2—C8—C9 127.7 (3) C16—C15—H15B 109.7
N2—C8—O1 112.5 (3) C15—C16—H16 109.4
O1—C8—C9 119.8 (3) C15—C16—C17 110.1 (3)
C8—C9—C10 110.7 (3) C15—C16—C18 108.9 (3)
C8—C9—C14 107.7 (3) C17—C16—H16 109.4
C8—C9—C18 111.2 (3) C17—C16—C18 109.5 (3)
C14—C9—C10 109.3 (3) C18—C16—H16 109.4
C14—C9—C18 109.1 (3) C13—C17—C16 109.2 (3)
C18—C9—C10 108.9 (3) C13—C17—H17A 109.8
C9—C10—H10A 109.8 C13—C17—H17B 109.8
C9—C10—H10B 109.8 C16—C17—H17A 109.8
H10A—C10—H10B 108.3 C16—C17—H17B 109.8
C11—C10—C9 109.3 (3) H17A—C17—H17B 108.3
C11—C10—H10A 109.8 C9—C18—H18A 109.8
C11—C10—H10B 109.8 C9—C18—H18B 109.8
C10—C11—H11 109.4 C16—C18—C9 109.6 (3)
C12—C11—C10 109.2 (3) C16—C18—H18A 109.8
C12—C11—H11 109.4 C16—C18—H18B 109.8
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C15—C11—C10 109.7 (3) H18A—C18—H18B 108.2
C15—C11—H11 109.4 C7—N1—N2 106.2 (3)
C15—C11—C12 109.6 (3) C8—N2—N1 106.3 (3)
C11—C12—H12A 109.7 C7—O1—C8 102.0 (3)
C11—C12—H12B 109.7
C1—C2—C3—C4 −1.1 (6) C11—C15—C16—C17 −59.2 (4)
C2—C1—C6—C5 1.1 (6) C11—C15—C16—C18 60.8 (4)
C2—C3—C4—C5 2.2 (6) C12—C11—C15—C16 59.0 (4)
C2—C3—C4—C7 −178.3 (3) C12—C13—C14—C9 59.4 (4)
C3—C4—C5—C6 −1.6 (6) C12—C13—C17—C16 −59.5 (4)
C3—C4—C7—N1 −18.2 (6) C14—C9—C10—C11 59.8 (4)
C3—C4—C7—O1 158.6 (3) C14—C9—C18—C16 −59.3 (4)
C4—C5—C6—C1 0.0 (6) C14—C13—C17—C16 60.6 (4)
C4—C7—N1—N2 176.5 (4) C15—C11—C12—C13 −59.5 (4)
C4—C7—O1—C8 −176.9 (3) C15—C16—C17—C13 59.3 (4)
C5—C4—C7—N1 161.3 (4) C15—C16—C18—C9 −60.5 (4)
C5—C4—C7—O1 −22.0 (5) C17—C13—C14—C9 −60.7 (4)
C6—C1—C2—C3 −0.5 (6) C17—C16—C18—C9 59.9 (4)
C7—C4—C5—C6 178.9 (4) C18—C9—C10—C11 −59.3 (4)
C7—N1—N2—C8 0.4 (4) C18—C9—C14—C13 59.8 (4)
C8—C9—C10—C11 178.1 (3) C18—C16—C17—C13 −60.5 (4)
C8—C9—C14—C13 −179.4 (3) F1—C1—C2—C3 178.7 (3)
C8—C9—C18—C16 −177.9 (3) F1—C1—C6—C5 −178.2 (3)
C9—C8—N2—N1 179.3 (4) N1—C7—O1—C8 0.3 (4)
C9—C8—O1—C7 −179.6 (3) N2—C8—C9—C10 −111.7 (4)
C9—C10—C11—C12 −60.3 (4) N2—C8—C9—C14 7.7 (6)
C9—C10—C11—C15 59.8 (4) N2—C8—C9—C18 127.1 (4)
C10—C9—C14—C13 −59.2 (4) N2—C8—O1—C7 −0.1 (4)
C10—C9—C18—C16 59.8 (4) O1—C7—N1—N2 −0.4 (4)
C10—C11—C12—C13 60.7 (4) O1—C8—C9—C10 67.8 (4)
C10—C11—C15—C16 −60.9 (4) O1—C8—C9—C14 −172.9 (3)
C11—C12—C13—C14 −60.0 (4) O1—C8—C9—C18 −53.4 (4)
C11—C12—C13—C17 60.0 (4) O1—C8—N2—N1 −0.2 (4)
Hydrogen-bond geometry (Å, º) 
Cg1 is the centroid of the C1–C6 ring.
D—H···A D—H H···A D···A D—H···A
C3—H3···N1i 0.95 2.56 3.383 (5) 146
C18—H18A···F1ii 0.99 2.47 3.415 (5) 159
Symmetry codes: (i) −x+1, −y+1, −z+1; (ii) −x+1, y−1/2, −z+3/2.
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a = 13.08241 (19) Å
b = 6.49259 (9) Å
c = 18.5129 (3) Å
β = 105.5609 (16)°
V = 1514.83 (4) Å3
Z = 4
F(000) = 664
Dx = 1.380 Mg m−3
Cu Kα radiation, λ = 1.54184 Å
Cell parameters from 11758 reflections
θ = 3.7–79.0°
µ = 2.25 mm−1
T = 160 K
Needle, colourless
0.33 × 0.12 × 0.08 mm
Data collection 
XtaLAB Synergy, Dualflex, Pilatus 200K 
diffractometer
Radiation source: micro-focus sealed X-ray 
tube, PhotonJet (Cu) X-ray Source
Mirror monochromator
Detector resolution: 5.8140 pixels mm-1
ω scans
Absorption correction: analytical 
(CrysAlisPro; Rigaku OD, 2019)
Tmin = 0.642, Tmax = 0.870
14318 measured reflections
3217 independent reflections
3052 reflections with I > 2σ(I)
Rint = 0.023













Primary atom site location: dual
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.094P)2 + 1.5575P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.81 e Å−3
Δρmin = −0.26 e Å−3
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
C1 0.42626 (17) 0.6044 (4) 0.35491 (12) 0.0302 (5)
C2 0.40263 (17) 0.4056 (4) 0.37203 (12) 0.0317 (5)
H2 0.333320 0.351478 0.352048 0.038*
C3 0.48137 (17) 0.2855 (4) 0.41883 (12) 0.0279 (5)
H3 0.466239 0.148920 0.431206 0.034*
C4 0.58338 (16) 0.3685 (3) 0.44753 (11) 0.0254 (4)
C5 0.60437 (17) 0.5705 (3) 0.43076 (12) 0.0280 (5)
H5 0.672884 0.627166 0.451644 0.034*
C6 0.52611 (17) 0.6897 (4) 0.38380 (13) 0.0302 (5)
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H6 0.540617 0.826921 0.371688 0.036*
C7 0.66623 (17) 0.2413 (3) 0.49555 (12) 0.0229 (4)
C8 0.81754 (16) 0.1694 (3) 0.56872 (11) 0.0238 (4)
C9 0.92972 (16) 0.2106 (3) 0.61176 (11) 0.0219 (4)
C10 0.93691 (16) 0.3930 (4) 0.66595 (12) 0.0282 (5)
H10A 0.897237 0.360738 0.703168 0.034*
H10B 0.904931 0.517124 0.637722 0.034*
C11 1.05425 (18) 0.4345 (4) 0.70636 (13) 0.0314 (5)
H11 1.059032 0.553003 0.741610 0.038*
C12 1.1016 (2) 0.2426 (4) 0.75071 (13) 0.0333 (5)
H12A 1.062078 0.209782 0.787976 0.040*
H12B 1.176566 0.268774 0.778004 0.040*
C13 1.09521 (18) 0.0597 (4) 0.69691 (13) 0.0319 (5)
H13 1.126743 −0.065180 0.726092 0.038*
C14 0.97843 (17) 0.0175 (3) 0.65594 (12) 0.0285 (5)
H14A 0.938650 −0.018439 0.692756 0.034*
H14B 0.973710 −0.100189 0.621181 0.034*
C15 1.11625 (17) 0.4853 (3) 0.64960 (14) 0.0319 (5)
H15A 1.191412 0.512639 0.676075 0.038*
H15B 1.086479 0.610423 0.621095 0.038*
C16 1.10922 (16) 0.3031 (4) 0.59555 (13) 0.0284 (5)
H16 1.149192 0.336599 0.557972 0.034*
C17 1.15702 (17) 0.1113 (4) 0.63970 (14) 0.0330 (5)
H17A 1.232475 0.136605 0.665944 0.040*
H17B 1.153464 −0.006047 0.604985 0.040*
C18 0.99249 (17) 0.2645 (3) 0.55507 (12) 0.0231 (4)
H18A 0.987062 0.149794 0.518988 0.028*
H18B 0.961848 0.389182 0.526636 0.028*
Cl1 0.32838 (4) 0.75434 (10) 0.29606 (3) 0.0384 (2)
N1 0.66468 (15) 0.0461 (3) 0.50869 (12) 0.0348 (5)
N2 0.76544 (15) −0.0012 (3) 0.55744 (12) 0.0330 (4)
O1 0.76044 (11) 0.3299 (2) 0.53130 (8) 0.0254 (3)
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
C1 0.0236 (10) 0.0423 (13) 0.0245 (10) 0.0028 (9) 0.0060 (8) 0.0015 (9)
C2 0.0215 (9) 0.0424 (13) 0.0291 (10) −0.0040 (9) 0.0036 (8) −0.0017 (9)
C3 0.0218 (10) 0.0354 (11) 0.0263 (10) −0.0056 (8) 0.0060 (8) −0.0019 (8)
C4 0.0218 (9) 0.0291 (11) 0.0248 (9) −0.0027 (8) 0.0054 (7) −0.0014 (8)
C5 0.0232 (9) 0.0290 (11) 0.0307 (10) −0.0028 (8) 0.0050 (8) −0.0010 (8)
C6 0.0256 (10) 0.0341 (11) 0.0310 (11) −0.0006 (9) 0.0077 (8) 0.0012 (9)
C7 0.0186 (9) 0.0250 (10) 0.0244 (10) −0.0048 (7) 0.0045 (8) −0.0021 (7)
C8 0.0236 (9) 0.0217 (10) 0.0263 (9) −0.0011 (8) 0.0069 (8) −0.0003 (8)
C9 0.0200 (9) 0.0223 (9) 0.0233 (9) −0.0016 (7) 0.0055 (7) −0.0007 (7)
C10 0.0248 (10) 0.0286 (11) 0.0303 (10) 0.0010 (8) 0.0056 (8) −0.0073 (8)
C11 0.0292 (11) 0.0290 (11) 0.0311 (11) −0.0009 (9) −0.0001 (8) −0.0078 (9)
C12 0.0294 (11) 0.0431 (14) 0.0233 (10) −0.0022 (9) −0.0001 (9) 0.0021 (8)
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C13 0.0289 (11) 0.0258 (11) 0.0349 (11) 0.0003 (9) −0.0018 (9) 0.0083 (9)
C14 0.0285 (10) 0.0229 (10) 0.0314 (10) −0.0029 (8) 0.0034 (8) 0.0052 (8)
C15 0.0238 (10) 0.0234 (10) 0.0432 (12) −0.0052 (8) −0.0004 (9) 0.0036 (9)
C16 0.0205 (10) 0.0332 (11) 0.0322 (11) −0.0003 (8) 0.0081 (8) 0.0056 (9)
C17 0.0251 (10) 0.0296 (11) 0.0413 (12) 0.0057 (9) 0.0036 (9) 0.0000 (9)
C18 0.0213 (9) 0.0254 (10) 0.0225 (9) −0.0001 (7) 0.0059 (8) 0.0018 (7)
Cl1 0.0242 (3) 0.0543 (4) 0.0342 (3) 0.0096 (2) 0.0034 (2) 0.0102 (2)
N1 0.0268 (9) 0.0279 (10) 0.0437 (11) −0.0052 (7) −0.0007 (8) 0.0024 (8)
N2 0.0258 (9) 0.0255 (9) 0.0426 (11) −0.0055 (7) 0.0000 (8) 0.0036 (8)
O1 0.0203 (7) 0.0236 (7) 0.0300 (7) −0.0035 (6) 0.0030 (6) 0.0005 (6)
Geometric parameters (Å, º) 
C1—C2 1.384 (4) C11—H11 1.0000
C1—C6 1.387 (3) C11—C12 1.529 (3)
C1—Cl1 1.740 (2) C11—C15 1.526 (3)
C2—H2 0.9500 C12—H12A 0.9900
C2—C3 1.393 (3) C12—H12B 0.9900
C3—H3 0.9500 C12—C13 1.538 (3)
C3—C4 1.405 (3) C13—H13 1.0000
C4—C5 1.391 (3) C13—C14 1.537 (3)
C4—C7 1.460 (3) C13—C17 1.532 (3)
C5—H5 0.9500 C14—H14A 0.9900
C5—C6 1.388 (3) C14—H14B 0.9900
C6—H6 0.9500 C15—H15A 0.9900
C7—N1 1.292 (3) C15—H15B 0.9900
C7—O1 1.360 (2) C15—C16 1.536 (3)
C8—C9 1.494 (3) C16—H16 1.0000
C8—N2 1.288 (3) C16—C17 1.528 (3)
C8—O1 1.359 (3) C16—C18 1.531 (3)
C9—C10 1.538 (3) C17—H17A 0.9900
C9—C14 1.539 (3) C17—H17B 0.9900
C9—C18 1.536 (3) C18—H18A 0.9900
C10—H10A 0.9900 C18—H18B 0.9900
C10—H10B 0.9900 N1—N2 1.417 (3)
C10—C11 1.540 (3)
C2—C1—C6 122.0 (2) C11—C12—C13 109.73 (18)
C2—C1—Cl1 119.56 (17) H12A—C12—H12B 108.2
C6—C1—Cl1 118.48 (19) C13—C12—H12A 109.7
C1—C2—H2 120.3 C13—C12—H12B 109.7
C1—C2—C3 119.4 (2) C12—C13—H13 109.5
C3—C2—H2 120.3 C14—C13—C12 109.36 (19)
C2—C3—H3 120.3 C14—C13—H13 109.5
C2—C3—C4 119.3 (2) C17—C13—C12 109.38 (19)
C4—C3—H3 120.3 C17—C13—H13 109.5
C3—C4—C7 119.2 (2) C17—C13—C14 109.69 (18)
C5—C4—C3 120.1 (2) C9—C14—H14A 109.8
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C5—C4—C7 120.68 (19) C9—C14—H14B 109.8
C4—C5—H5 119.7 C13—C14—C9 109.39 (17)
C6—C5—C4 120.6 (2) C13—C14—H14A 109.8
C6—C5—H5 119.7 C13—C14—H14B 109.8
C1—C6—C5 118.6 (2) H14A—C14—H14B 108.2
C1—C6—H6 120.7 C11—C15—H15A 109.8
C5—C6—H6 120.7 C11—C15—H15B 109.8
N1—C7—C4 128.6 (2) C11—C15—C16 109.40 (18)
N1—C7—O1 112.39 (19) H15A—C15—H15B 108.2
O1—C7—C4 119.03 (17) C16—C15—H15A 109.8
N2—C8—C9 129.94 (19) C16—C15—H15B 109.8
N2—C8—O1 112.47 (18) C15—C16—H16 109.5
O1—C8—C9 117.48 (17) C17—C16—C15 109.55 (18)
C8—C9—C10 111.42 (17) C17—C16—H16 109.5
C8—C9—C14 110.16 (17) C17—C16—C18 109.88 (18)
C8—C9—C18 107.76 (17) C18—C16—C15 108.81 (17)
C10—C9—C14 109.67 (17) C18—C16—H16 109.5
C18—C9—C10 108.65 (17) C13—C17—H17A 109.8
C18—C9—C14 109.12 (17) C13—C17—H17B 109.8
C9—C10—H10A 109.8 C16—C17—C13 109.39 (18)
C9—C10—H10B 109.8 C16—C17—H17A 109.8
C9—C10—C11 109.27 (17) C16—C17—H17B 109.8
H10A—C10—H10B 108.3 H17A—C17—H17B 108.2
C11—C10—H10A 109.8 C9—C18—H18A 109.6
C11—C10—H10B 109.8 C9—C18—H18B 109.6
C10—C11—H11 109.3 C16—C18—C9 110.41 (17)
C12—C11—C10 109.02 (19) C16—C18—H18A 109.6
C12—C11—H11 109.3 C16—C18—H18B 109.6
C15—C11—C10 110.36 (18) H18A—C18—H18B 108.1
C15—C11—H11 109.3 C7—N1—N2 105.90 (18)
C15—C11—C12 109.41 (19) C8—N2—N1 106.14 (18)
C11—C12—H12A 109.7 C8—O1—C7 103.10 (16)
C11—C12—H12B 109.7
Hydrogen-bond geometry (Å, º) 
Cg1 is the centroid of the C1–C6 ring.
D—H···A D—H H···A D···A D—H···A
C3—H3···N1i 0.95 2.61 3.386 (3) 139
C12—H12A···Cg1ii 0.99 2.73 3.680 (3) 160
Symmetry codes: (i) −x+1, −y, −z+1; (ii) x+1/2, −y+1/2, z+1/2.
